Combining Acute Diffusion-Weighted Imaging and Mean Transmit Time Lesion Volumes With National Institutes of Health Stroke Scale Score Improves the Prediction of Acute Stroke Outcome
暂无分享,去创建一个
Pamela W Schaefer | W. Copen | L. Schwamm | P. Schaefer | A. Yoo | L. Gharai | S. Kamalian | Albert J Yoo | Lee H Schwamm | Elizabeth R Barak | William A Copen | Shahmir Kamalian | Leila Rezai Gharai | Muhammad A Pervez | R Gilberto González | M. A. Pervez | R. González | Elizabeth R. Barak
[1] Keith Muir,et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial , 2008, The Lancet Neurology.
[2] P Sandercock,et al. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[3] S. Warach,et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.
[4] G. Schlaug,et al. Evaluation of the Clinical–Diffusion and Perfusion–Diffusion Mismatch Models in DEFUSE , 2007, Stroke.
[5] P. Barber,et al. Clinical–Diffusion Mismatch and Benefit From Thrombolysis 3 to 6 Hours After Acute Stroke , 2009, Stroke.
[6] L. Caplan,et al. Stroke Thrombolysis: Slow Progress , 2006, Circulation.
[7] Wade S. Smith,et al. Prognostic significance of angiographically confirmed large vessel intracranial occlusion in patients presenting with acute brain ischemia , 2006, Neurocritical care.
[8] C. Weiller,et al. Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients: Comparison of a German Multicenter Study With the Pooled Data of ATLANTIS, ECASS, and NINDS tPA Trials , 2006, Stroke.
[9] S. Warach,et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study , 2009, The Lancet Neurology.
[10] K. Pettigrew,et al. Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. , 1999, Stroke.
[11] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[12] Brian Silver,et al. A three-item scale for the early prediction of stroke recovery , 2001, The Lancet.
[13] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[14] M. Kaste,et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.
[15] R. Gonzalez,et al. MRI-Based Selection for Intra-Arterial Stroke Therapy: Value of Pretreatment Diffusion-Weighted Imaging Lesion Volume in Selecting Patients With Acute Stroke Who Will Benefit From Early Recanalization , 2009, Stroke.
[16] B. Rosen,et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.
[17] A. Villringer,et al. Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 Hours , 2002, Stroke.
[18] W. Hacke,et al. Mismatch-Based Delayed Thrombolysis: A Meta-Analysis , 2010, Stroke.
[19] P. Kaňovský,et al. Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis , 2006, Neuroradiology.
[20] À. Rovira,et al. Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol , 2005, Stroke.
[21] Jeffrey L Saver,et al. The Impact of Recanalization on Ischemic Stroke Outcome: A Meta-Analysis , 2007, Stroke.
[22] M. Vangel,et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes , 2009, Neurology.
[23] Henry Ma,et al. Penumbral selection of patients for trials of acute stroke therapy , 2009, The Lancet Neurology.
[24] Scott Hamilton,et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study , 2006, Annals of neurology.
[25] H. Moriwaki,et al. Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes , 2008, Neurology.
[26] Steven Warach,et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of Safety and Efficacy 3 to 9 Hours After Stroke Onset , 2006, Stroke.
[27] Patricia Desmond,et al. Clinical-Diffusion Mismatch Predicts the Putative Penumbra With High Specificity , 2005, Stroke.
[28] T. Neumann-Haefelin,et al. MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows: An Analysis of 1210 Patients , 2007, Stroke.